Susquehanna Fundamental Investments’s Agilon Health AGL Stock Holding History

Susquehanna Fundamental Investments’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-993	Closed	-$25.6K	–	556
2025 Q3	$25.6K	Hold	993	–	–	﹤0.01%	550
2025 Q2	$57.1K	Sell	993 -11,436	-92%	-$917K	﹤0.01%	703
2025 Q1	$1.35M	Sell	12,429 -21,596	-63%	-$1.88M	0.02%	620
2024 Q4	$1.62M	Buy	+34,025	New	+$2.06M	0.02%	587
2024 Q2	$5.26M	Buy	32,184 +12,674	+65%	+$1.81M	0.12%	222
2024 Q1	$2.98M	Buy	+19,510	New	+$3.25M	0.14%	179

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NPCM

North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Susquehanna Fundamental Investments's AGL Position: Q4 2025 in Review

Susquehanna Fundamental Investments sold out of Agilon Health (AGL) in Q4 2025, closing a stake of 993 shares — an estimated $25.6K sold.

Susquehanna Fundamental Investments first reported a position in AGL in Q1 2024 and held it in 6 quarters. The position peaked at $5.26M in Q2 2024. 194 funds tracked by Wall St. Rank hold AGL as of Q4 2025.

Susquehanna Fundamental Investments reported no remaining Agilon Health position as of Q4 2025 after selling out during the quarter.
Susquehanna Fundamental Investments sold 993 Agilon Health shares in Q4 2025, an estimated $25.6K.
Susquehanna Fundamental Investments first reported a position in Agilon Health in Q1 2024 and held it in 6 quarters.
Susquehanna Fundamental Investments's Agilon Health position peaked at $5.26M in Q2 2024.
194 funds tracked by Wall St. Rank held Agilon Health as of Q4 2025.

Based on Susquehanna Fundamental Investments's 13F filing for Q4 2025, filed 17 Feb 2026.